Literature DB >> 8245080

Massive allografts sterilised by irradiation. Clinical results.

P Hernigou1, G Delepine, D Goutallier, A Julieron.   

Abstract

From 1984 to 1988 we implanted 127 massive allografts irradiated with a dose of 25,000 grays. These were reviewed at a minimum follow-up of three years to determine the effect of irradiation on infection, the complications and the functional result. No bacteriological infection was seen in the 44 patients who had allografts for revision of joint arthroplasty or for a tumour with no adjuvant therapy. For the 83 patients who also had chemotherapy or radiotherapy or both for a bone tumour, the rate of infection was 13%. The major mechanical complications were nonunion in seven grafts (5.5%) and fracture in eight (6%). These rates do not differ greatly from those reported for non-irradiated grafts. Our results suggest that irradiation, which remains the most convenient and acceptable method of sterilisation, does not jeopardize the clinical results.

Entities:  

Mesh:

Year:  1993        PMID: 8245080

Source DB:  PubMed          Journal:  J Bone Joint Surg Br        ISSN: 0301-620X


  12 in total

1.  Bone transplantation and tissue engineering, part III: allografts, bone grafting and bone banking in the twentieth century.

Authors:  Philippe Hernigou
Journal:  Int Orthop       Date:  2015-01-21       Impact factor: 3.075

2.  Supercharging irradiated allografts with mesenchymal stem cells improves acetabular bone grafting in revision arthroplasty.

Authors:  Philippe Hernigou; Jacques Pariat; Steffen Queinnec; Yasuhiro Homma; Charles Henri Flouzat Lachaniette; Nathalie Chevallier; Helene Rouard
Journal:  Int Orthop       Date:  2014-02-09       Impact factor: 3.075

Review 3.  Radiation sterilization of tissue allografts: A review.

Authors:  Rita Singh; Durgeshwer Singh; Antaryami Singh
Journal:  World J Radiol       Date:  2016-04-28

4.  Regenerative therapy with mesenchymal stem cells at the site of malignant primary bone tumour resection: what are the risks of early or late local recurrence?

Authors:  Philippe Hernigou; Charles Henri Flouzat Lachaniette; Jerome Delambre; Nathalie Chevallier; Helene Rouard
Journal:  Int Orthop       Date:  2014-06-07       Impact factor: 3.075

5.  Allografts supercharged with bone-marrow-derived mesenchymal stem cells possess equivalent osteogenic capacity to that of autograft: a study with long-term follow-ups of human biopsies.

Authors:  Philippe Hernigou; Arnaud Dubory; François Roubineau; Yasuhiro Homma; Charles Henri Flouzat-Lachaniette; Nathalie Chevallier; Helene Rouard
Journal:  Int Orthop       Date:  2016-08-24       Impact factor: 3.075

Review 6.  Megaprosthesis Versus Allograft Prosthesis Composite for the Management of Massive Skeletal Defects: A Meta-Analysis of Comparative Studies.

Authors:  Deepak Gautam; Nitish Arora; Saurabh Gupta; Jaiben George; Rajesh Malhotra
Journal:  Curr Rev Musculoskelet Med       Date:  2021-04-17

7.  Massive intercalary bone allografts in the treatment of primary and secondary bone tumors. A report on 21 cases.

Authors:  G Voggenreiter; W Klaes; S Assenmacher; K P Schmit-Neuerburg
Journal:  Arch Orthop Trauma Surg       Date:  1995       Impact factor: 3.067

8.  Risk of amputation following limb salvage surgery with endoprosthetic replacement, in a consecutive series of 1261 patients.

Authors:  L M Jeys; R J Grimer; S R Carter; R M Tillman
Journal:  Int Orthop       Date:  2003-02-08       Impact factor: 3.075

9.  Knee chondrosarcoma secondary to Ollier's disease: a report of one case with twelve-year follow-up.

Authors:  Philippe Chiron; Jérôme Murgier
Journal:  Orthop Rev (Pavia)       Date:  2012-05-29

10.  Effect of accelerated electron beam on mechanical properties of human cortical bone: influence of different processing methods.

Authors:  Artur Kaminski; Ewelina Grazka; Anna Jastrzebska; Joanna Marowska; Grzegorz Gut; Artur Wojciechowski; Izabela Uhrynowska-Tyszkiewicz
Journal:  Cell Tissue Bank       Date:  2012-05-16       Impact factor: 1.522

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.